Health X Platform Promoter Group Increases Stake to 74.84% Through Market Purchases

2 min read     Updated on 28 Mar 2026, 11:13 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Health X Platform Limited disclosed promoter group acquisitions totaling 1,90,355 shares through market purchases between November 2025 and March 2026. The promoter group's collective shareholding increased from 74.24% to 74.84%, with Banwari Lal Mittal acquiring 1,70,355 shares to reach 33.91% individual holding and Luv Kush Projects Limited adding 20,000 shares to achieve 11.96% stake.

powered bylight_fuzz_icon
35814436

*this image is generated using AI for illustrative purposes only.

Health X Platform Limited (formerly Sastasundar Ventures Limited) has disclosed substantial share acquisitions by its promoter group under SEBI Takeover Regulations. The comprehensive acquisition involved multiple transactions between November 2025 and March 2026, demonstrating sustained confidence in the company's prospects.

Promoter Group Acquisition Details

The promoter group, led by Banwari Lal Mittal, acquired a total of 1,90,355 equity shares through market purchases. The acquisition period spanned from November 17, 2025, to March 24, 2026, with transactions conducted on the open market.

Parameter: Details
Total Shares Acquired: 1,90,355 equity shares
Acquisition Period: November 17, 2025 to March 24, 2026
Transaction Mode: Market Purchase
Percentage Increase: 0.5984%
Stock Exchanges: BSE (533259) and NSE (SASTASUNDR)

Updated Promoter Group Shareholding Pattern

The acquisitions resulted in a significant increase in the promoter group's collective shareholding. The group's total holding now represents nearly three-quarters of the company's equity capital.

Shareholding Status: Before Acquisition After Acquisition Change
Total Promoter Shares: 2,36,15,272 2,38,05,627 +1,90,355
Percentage Holding: 74.24% 74.84% +0.60%
Equity Share Capital: 3,18,10,500 shares 3,18,10,500 shares No change

Individual Promoter Holdings

Banwari Lal Mittal emerged as the primary acquirer within the promoter group, significantly increasing his individual stake. Luv Kush Projects Limited also participated in the acquisition drive.

Promoter Name: Shares Acquired New Holding New Percentage
Banwari Lal Mittal: 1,70,355 1,07,86,355 33.91%
Luv Kush Projects Limited: 20,000 38,05,234 11.96%
Other Promoters: No change - -

Regulatory Compliance and Disclosure

Health X Platform Limited fulfilled its regulatory obligations by submitting the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The disclosure was communicated to both BSE and NSE on March 27, 2026.

Key compliance highlights include:

  • Comprehensive promoter group details provided
  • Timely disclosure within prescribed timeframes
  • Proper documentation with acquirer signatures
  • Communication to designated stock exchanges
  • Complete shareholding pattern transparency

The company operates under ISIN INE019J01013 and maintains listings on both major Indian stock exchanges. The continued acquisitions reflect the promoter group's sustained investment confidence and strategic commitment to the company's growth trajectory.

Historical Stock Returns for Sastasundar Ventures

1 Day5 Days1 Month6 Months1 Year5 Years
+5.08%-2.56%-4.68%-11.49%+6.73%+136.95%

What strategic initiatives or expansion plans might Health X Platform be pursuing that prompted such sustained promoter confidence over this 4-month acquisition period?

How might the increased promoter concentration at 74.84% affect minority shareholder interests and the company's ability to raise external capital for future growth?

Could this significant promoter stake increase signal preparation for a potential delisting or privatization of Health X Platform?

Health X Platform Limited Promoter Banwari Lal Mittal Continues Share Acquisitions

1 min read     Updated on 19 Mar 2026, 11:39 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Health X Platform Limited disclosed another share acquisition by promoter Banwari Lal Mittal, who purchased 7,663 equity shares worth Rs. 21.26 lakh through market purchase between March 16-17, 2026. This transaction increased his shareholding from 33.8522% to 33.8763%, representing a net increase of 0.0241%. The company submitted the regulatory disclosure under SEBI Insider Trading Regulations to BSE and NSE on March 19, 2026.

powered bylight_fuzz_icon
34933338

*this image is generated using AI for illustrative purposes only.

Health X Platform Limited has informed stock exchanges about another acquisition of additional equity shares by its promoter Mr. Banwari Lal Mittal. The company disclosed this latest transaction under Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015 on March 19, 2026.

Latest Share Acquisition Details

Mr. Banwari Lal Mittal, a promoter of Health X Platform Limited, acquired 7,663 equity shares through market purchase in his most recent transaction. The updated transaction details are presented below:

Parameter: Details
Number of Shares Acquired: 7,663 equity shares
Transaction Value: Rs. 21,26,214.13 (inclusive of taxes)
Transaction Period: March 16, 2026 to March 17, 2026
Mode of Acquisition: Market Purchase
Date of Intimation: March 18, 2026

Updated Shareholding Pattern

The latest acquisition resulted in a further increase in Mr. Mittal's shareholding in the company. His current shareholding position reflects the cumulative effect of recent transactions:

Shareholding Status: Number of Shares Percentage of Capital
Prior to Latest Acquisition: 1,07,68,560 33.8522%
Post Latest Acquisition: 1,07,76,223 33.8763%
Net Increase: 7,663 0.0241%

Regulatory Compliance

Health X Platform Limited, formerly known as Sastasundar Ventures Limited, submitted the latest disclosure to both BSE Limited and National Stock Exchange of India Limited. The company trades under stock code 533259 on BSE and symbol SASTASUNDR on NSE.

The disclosure was made in Form C as specified under Regulation 7(2)(a) of the SEBI (Prohibition of Insider Trading) Regulations, 2015. Company Secretary and Compliance Officer Pratap Singh digitally signed the disclosure documents on March 19, 2026, on behalf of the company.

Company Information

Health X Platform Limited operates with CIN L65993WB1989PLC047002 and maintains its registered office at Azimganj House, 2nd Floor, 7, Abanindra Nath Thakur Sarani, Kolkata. The company's ISIN is INE019J01013, and it continues to operate under its healthcare and platform business model following its name change from Sastasundar Ventures Limited.

Historical Stock Returns for Sastasundar Ventures

1 Day5 Days1 Month6 Months1 Year5 Years
+5.08%-2.56%-4.68%-11.49%+6.73%+136.95%

Will Mr. Mittal's continued share accumulation signal a potential delisting or privatization attempt for Health X Platform Limited?

How might this promoter buying activity impact Health X Platform's stock price and trading volumes in the coming quarters?

Could this acquisition pattern indicate upcoming strategic initiatives or major business expansion plans for the healthcare platform?

More News on Sastasundar Ventures

1 Year Returns:+6.73%